Al-Eitan L, ElMotasem M, Khair I, Alahmad S
Curr Pharm Des. 2024; 30(13):1031-1047.
PMID: 38898820
DOI: 10.2174/0113816128280417231204085137.
Ahmadvand M, Shokrollahi Barough M, Barkhordar M, Faridfar A, Ghaderi A, Jalaeikhoo H
BMC Cancer. 2023; 23(1):1090.
PMID: 37950209
PMC: 10636850.
DOI: 10.1186/s12885-023-11610-x.
Abatay Sel F, Savran Oguz F
Ann Hematol. 2023; 103(4):1035-1047.
PMID: 37801085
DOI: 10.1007/s00277-023-05448-3.
Le Bourgeois A, Jullien M, Garnier A, Peterlin P, Bene M, Guillaume T
Clin Transl Med. 2023; 13(4):e1242.
PMID: 37140099
PMC: 10131294.
DOI: 10.1002/ctm2.1242.
Plesa A, Tigaud I, Hayette S, Roumier C, Thomas X
Oncol Ther. 2022; 10(1):75-84.
PMID: 35129793
PMC: 9098757.
DOI: 10.1007/s40487-021-00180-2.
A Census of Tandemly Repeated Polymorphic Loci in Genic Regions Through the Comparative Integration of Human Genome Assemblies.
Genovese L, Geraci F, Corrado L, Mangano E, DAurizio R, Bordoni R
Front Genet. 2018; 9:155.
PMID: 29770143
PMC: 5941971.
DOI: 10.3389/fgene.2018.00155.
A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma.
Federico S, McCarville M, Shulkin B, Sondel P, Hank J, Hutson P
Clin Cancer Res. 2017; 23(21):6441-6449.
PMID: 28939747
PMC: 8725652.
DOI: 10.1158/1078-0432.CCR-17-0379.
Consolidation Therapy for Newly Diagnosed Pediatric Patients with High-Risk Neuroblastoma Using Busulfan/Melphalan, Autologous Hematopoietic Cell Transplantation, Anti-GD2 Antibody, Granulocyte-Macrophage Colony-Stimulating Factor, Interleukin-2,....
Talleur A, Triplett B, Federico S, Mamcarz E, Janssen W, Wu J
Biol Blood Marrow Transplant. 2017; 23(11):1910-1917.
PMID: 28733263
PMC: 5682204.
DOI: 10.1016/j.bbmt.2017.07.011.
Haplotype counting by next-generation sequencing for ultrasensitive human DNA detection.
Debeljak M, Freed D, Welch J, Haley L, Beierl K, Iglehart B
J Mol Diagn. 2014; 16(5):495-503.
PMID: 25132481
PMC: 5691345.
DOI: 10.1016/j.jmoldx.2014.04.003.
Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial.
Chevallier P, Labopin M, Socie G, Tabrizi R, Furst S, Lioure B
Haematologica. 2014; 99(9):1486-91.
PMID: 24951467
PMC: 4562538.
DOI: 10.3324/haematol.2014.108563.
Rapid determination of chimerism status using dihydrorhodamine assay in a patient with X-linked chronic granulomatous disease following hematopoietic stem cell transplantation.
Kim H, Kim H, Ki C, Kim D, Yoo K, Kang E
Ann Lab Med. 2013; 33(4):288-92.
PMID: 23826567
PMC: 3698309.
DOI: 10.3343/alm.2013.33.4.288.
Lineage switching in acute leukemias: a consequence of stem cell plasticity?.
Dorantes-Acosta E, Pelayo R
Bone Marrow Res. 2012; 2012:406796.
PMID: 22852088
PMC: 3407598.
DOI: 10.1155/2012/406796.
Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation.
Avery S, Voss M, Gonzales A, Lubin M, Castro-Malaspina H, Giralt S
Bone Marrow Transplant. 2011; 47(8):1056-60.
PMID: 22139066
PMC: 3970438.
DOI: 10.1038/bmt.2011.236.
Analysis of hematopoietic stem cell transplant engraftment: use of loss or gain of microsatellite alleles to identify residual hematopoietic malignancy.
Lin M, Tseng L, Beierl K, Harada S, Hafez M, Eshleman J
Diagn Mol Pathol. 2011; 20(4):194-202.
PMID: 22089346
PMC: 3219907.
DOI: 10.1097/PDM.0b013e31821dac16.
Factors predicting single-unit predominance after double umbilical cord blood transplantation.
Ramirez P, Wagner J, DeFor T, Blazar B, Verneris M, Miller J
Bone Marrow Transplant. 2011; 47(6):799-803.
PMID: 21946383
PMC: 3590908.
DOI: 10.1038/bmt.2011.184.
Quantifying the relative amount of mouse and human DNA in cancer xenografts using species-specific variation in gene length.
Lin M, Tseng L, Kamiyama H, Kamiyama M, Lim P, Hidalgo M
Biotechniques. 2010; 48(3):211-8.
PMID: 20359302
PMC: 3065779.
DOI: 10.2144/000113363.
NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia.
Rubnitz J, Inaba H, Ribeiro R, Pounds S, Rooney B, Bell T
J Clin Oncol. 2010; 28(6):955-9.
PMID: 20085940
PMC: 2834435.
DOI: 10.1200/JCO.2009.24.4590.
Systematic analysis of interference due to stutter in estimating chimerism following hematopoietic cell transplantation.
Thyagarajan B, Young S, Floodman S, Peterson R, Wang X
J Clin Lab Anal. 2009; 23(5):308-13.
PMID: 19774632
PMC: 6648958.
DOI: 10.1002/jcla.20336.
Quantitative tools for assessing the fate of xenotransplanted human stem/progenitor cells in chimeric mice.
Cheng K, Gupta S
Xenotransplantation. 2009; 16(3):145-51.
PMID: 19566654
PMC: 2787247.
DOI: 10.1111/j.1399-3089.2009.00526.x.
Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor.
Majhail N, Brunstein C, Tomblyn M, Thomas A, Miller J, Arora M
Biol Blood Marrow Transplant. 2008; 14(3):282-9.
PMID: 18275894
PMC: 2674378.
DOI: 10.1016/j.bbmt.2007.12.488.